Search

TG Therapeutics Inc

Abierto

SectorSanidad

53.28 -0.3

Resumen

Variación precio

24h

Actual

Mínimo

52.96

Máximo

54.98

Métricas clave

By Trading Economics

Ingresos

-3.3M

20M

Ventas

12M

205M

P/B

Media del Sector

19.021

50.958

BPA

0.18

Margen de beneficios

9.651

Empleados

399

EBITDA

-24M

28M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-1.74% downside

Dividendos

By Acuity

Próximas Ganancias

3 ago 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.9B

8.3B

Apertura anterior

53.58

Cierre anterior

53.28

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

146 / 342 Clasificación en Healthcare

TG Therapeutics Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

24 jun 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

24 jun 2026, 23:52 UTC

News
Correlated Moves
Social Media

Applied Materials shares rose in after-market trading, boosted by strong earnings from Micron Technology and positive sentiment in the semiconductor sector.

24 jun 2026, 23:52 UTC

News
Correlated Moves

Lam Research Corp shares rise in after-market trading, driven by positive sentiment from Micron Technology's strong results and broader semiconductor sector gains.

24 jun 2026, 23:41 UTC

News

The iShares Core U.S. Aggregate Bond ETF is trading lower in after-market hours, following a session marked by declines and mixed global market dynamics.

24 jun 2026, 23:41 UTC

News
Correlated Moves

Alphabet Inc. shares are lower in after-market hours, down $1.13 to about $345.00, amid a broader decline in the Interactive Media & Services sector.

24 jun 2026, 23:41 UTC

Event
News

Trip.com Group Ltd's stock is lower in after-market trading following a first-quarter net income decline and reduced second-quarter revenue guidance.

24 jun 2026, 23:41 UTC

ETF Constituents
News
Social Media

Invesco QQQ Trust Series I rises in after-market trading, boosted by strong Q3 earnings from Micron Technologies and positive sentiment from tech sector recovery.

24 jun 2026, 23:41 UTC

News
Correlated Moves

Western Digital shares rose sharply in after-hours trading following strong Q3 results from Micron Technology, which beat earnings and revenue expectations.

24 jun 2026, 23:41 UTC

Correlated Moves
News

iShares Silver Trust is trading higher in after-market hours, reflecting recovery after recent declines despite slight decreases in gold prices.

24 jun 2026, 23:41 UTC

Correlated Moves
News

SPDR Gold Shares advance in after-market trading despite lower gold prices and a slight decline in silver. U.S. stocks show generally higher performance.

24 jun 2026, 23:41 UTC

Correlated Moves
News
Social Media

Qualcomm shares rose after Investor Day, doubling fiscal 2029 non-handset revenue targets to $40 billion and announcing a partnership with Meta Platforms for data center CPUs.

24 jun 2026, 23:41 UTC

News

Comcast shares are higher after reports of its subsidiary Sky acquiring ITV's Broadcast unit for about £1.6 billion, pending legal review.

24 jun 2026, 23:36 UTC

News

Gilead Sciences' Trodelvy receives FDA approval for first-line treatment of triple-negative breast cancer, boosting shares in after-market hours.

24 jun 2026, 23:32 UTC

News
Event
Social Media

Micron Technology reported record third-quarter revenue of $41.46 billion and strong fourth-quarter guidance, driving shares higher in after-market trading.

24 jun 2026, 23:31 UTC

News
Social Media

United States Oil Fund LP is trading higher in after-market hours following a larger-than-expected drop in U.S. crude oil inventories for the week.

24 jun 2026, 23:11 UTC

Correlated Moves
News
Social Media

Meta shares rise in after-market trading following a strategic partnership with Qualcomm and government discussions on AI oversight.

24 jun 2026, 23:06 UTC

News
Social Media

Tesla Inc shares are higher in after-market trading, supported by a multi-year agreement with NatPower for battery energy storage systems in Europe.

24 jun 2026, 23:06 UTC

Correlated Moves
News

The iShares 7-10 Year Treasury Bond ETF is trading higher in after-market hours, reflecting routine movement near its one-month trading range.

24 jun 2026, 23:06 UTC

News
Correlated Moves
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust rises in after-market trading, aided by strong earnings from Micron Technologies and lower oil prices this week.

24 jun 2026, 23:05 UTC

News
Correlated Moves

The Vanguard Total Bond Market ETF is higher in after-market hours, reflecting broader market recovery amid easing concerns over U.S.-Iran negotiations affecting energy supply.

24 jun 2026, 23:02 UTC

News
ETF Constituents

The Vanguard Growth ETF is gaining in after-market trading, supported by strong performances from AMD and KLA Corporation. Oil prices have declined below $80 per barrel.

24 jun 2026, 23:02 UTC

News
Correlated Moves

The iShares 20+ Year Treasury Bond ETF is higher in after-market trading, buoyed by U.S. Bancorp's dividend increase and positive sentiment in fixed-income securities.

24 jun 2026, 23:02 UTC

News
ETF Constituents
Macro News

Vanguard Information Technology ETF gains after-hours, supported by Micron Technology's record earnings and strong performance from top holdings.

24 jun 2026, 23:01 UTC

News

Charter Communications Inc. gains in after-market trading, supported by positive sentiment from the Federal Reserve's stress test results and strong mobile segment growth.

24 jun 2026, 22:51 UTC

News

Booking Holdings Inc may benefit from falling oil prices, with WTI crude below $70 and Brent at $74, potentially boosting travel demand. Shares are roughly flat in after-market trading.

24 jun 2026, 20:07 UTC

News

Business confidence in Germany rose, lifting the EUR/ZAR higher during Wednesday's session. The Ifo index increased to 85.6 points, surpassing expectations.

24 jun 2026, 20:06 UTC

News
Correlated Moves

The US Dollar Index has risen, supporting higher trading in USD/DKK amid a broader trend of strength in the U.S. dollar.

24 jun 2026, 20:06 UTC

Macro Event
News
Correlated Moves

The U.S. current account deficit widened to $226.8 billion, influencing notable volatility in the USD/CZK exchange rate, which is higher since Tuesday's close.

24 jun 2026, 20:06 UTC

News
Correlated Moves

The US dollar's strength drives USD/SGD higher, reflecting a flight to safety amid economic and geopolitical concerns. The pair remains near its one-month trading range.

24 jun 2026, 20:06 UTC

News
Correlated Moves

USD/SEK is trading higher as the US Dollar Index strengthens amid a flight to safety, recovering from a midday dip while above its 20-day moving average.

Comparación entre iguales

Cambio de precio

TG Therapeutics Inc previsión

Precio Objetivo

By TipRanks

-1.74% descenso

Estimación a 12 Meses

Media 52.67 USD  -1.74%

Máximo 83 USD

Mínimo 17 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para TG Therapeutics Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

5

Comprar

1

Mantener

1

Vender

Sentimiento

By Acuity

146 / 342 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de TG Therapeutics Inc

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally. It provides BRIUMVI, an anti-CD20 monoclonal antibody for the treatment of adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease in adults. The company's development pipeline comprises Umbralisib, an oral inhibitor of PI3K-delta inhibitor for the treatment of adult patients with relapsed or refractory marginal zone lymphoma and follicular lymphoma; TG-1701 is an orally available and covalently bound Bruton's tyrosine kinase (BTK) inhibitor that exhibits selectivity to BTK in vitro kinase screening; and TG-1801, a bispecific CD47 and CD19 antibody. Its research pipeline includes various investigational medicines. The company has license agreements with LFB Biotechnologies S.A.S; GTC Biotherapeutics; LFB/GTC LLC; Ildong Pharmaceutical Co. Ltd.; Rhizen Pharmaceuticals, S A. for the development and commercialization of umbralisib; Jiangsu Hengrui Medicine Co.; and Novimmune SA, as well as collaboration agreement with Checkpoint Therapeutics, Inc. for the development and commercialization of anti-PD-L1 and anti-GITR antibody research programs in the field of hematological malignancies. TG Therapeutics, Inc. was incorporated in 1993 and is based in Morrisville, North Carolina.
help-icon Live chat